+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin



Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin



Journal of Oral Rehabilitation 46(5): 441-449



Oromandibular dystonia (OMD) with involuntary jaw and tongue movements may be misdiagnosed as temporomandibular disorders (TMD) and because of the complex muscle activity and involvement of several small muscles, OMD is also considered difficult to treat. The aim was to evaluate OMD in patients 8-10 years after start of treatment with botulinum toxin (BoNT) by self-reported and standardised global scales and questionnaires. Of 21 previously reported patients with OMD, 14 responded to a mail health questionnaire to describe the disease course and treatment effect as well as the overall impact of OMD by a visual analogue scale (VAS), the Patient Health Questionnaire (PHQ) for depression and anxiety, and the Jaw Functional Limitation Scale (JFLS). The results were analysed with non-parametric statistical analysis (Wilcoxon matched-pairs test and Spearman's rank-order correlations). The OMD was still present in 13 patients. In nine patients, the BoNT treatment had continued as monotherapy or combined with oral medication. VAS for OMD was significantly reduced (P < 0.04) over the years, and most patients felt improvement from the treatment. However, the patients had still some functional limitations, typically regarding jaw mobility and communication, and both JFLS and mental distress (PHQ) were significantly correlated with the OMD VAS (rS 0.77 and 0.74). The results showed marked reduction of the experienced OMD with treatment and over time, and also stressed similarities between OMD and TMD. Both dentists and neurologists should be aware of this overlap and reduce misdiagnosis by applying an interdisciplinary approach.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066108620

Download citation: RISBibTeXText

PMID: 30664806

DOI: 10.1111/joor.12768


Related references

Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. Seminars in Neurology 36(1): 84-91, 2016

Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 53(9): 2102-2107, 1999

Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue. Journal of Neurology 263(9): 1702-1708, 2016

Botulinum toxin treatment of oromandibular dystonia. Neurology 41(3 Suppl. 1): 274, 1991

Treatment of oromandibular dystonia with botulinum toxin. Laryngoscope 101(11): 1216-1218, 1991

Experience of botulinum toxin in treatment of oromandibular dystonia. Toxicon 123: S15-S16, 2016

Botulinum toxin treatment of patients with oromandibular dystonia. Ugeskrift for Laeger 162(48): 6567-6571, 2000

Botulinum toxin injection for the treatment of oromandibular dystonia. Annals of Otology Rhinology and Laryngology 98(2): 93-97, 1989

Botulinum toxin injections for the treatment of oromandibular dystonia. Operative Techniques in Otolaryngology-Head and Neck Surgery 15(2): 97-102, 2004

Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon 147: 96-99, 2018

Oromandibular dystonia Treatment of 96 patients with botulinum toxin type A. Jankovic, J , Hallett, M Neurological Disease and Therapy; Therapy with botulinum toxin 429-435, 1994

Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition. Neurologia i Neurochirurgia Polska 37(Suppl. 5): 55-60, 2003

Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. European Journal of Neurology 13(Suppl. 1): 21-29, 2006

Oromandibular dystonia in yemeni patients with khat chewing: a response to botulinum toxin treatment. Neurology International 6(2): 5385, 2014

Effects of botulinum toxin a on the improvement of dystonia among patients with oromandibular dystonia: A meta-analysis. Journal of the Neurological Sciences 381: 222-223, 2017